Clinical Trial Update: MK-0941 Multiple Dose Study in Japanese Patients With Type 2 Diabetes (MK-0941-011). [Phase 1]

View source ↗

Summary

This ClinicalTrials.gov entry reports the completion of a Phase 1 multiple-dose study of MK-0941 in Japanese patients with Type 2 diabetes mellitus, with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MK-0941

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus, Non-Insulin-Dependent | Phase 1 | Status: COMPLETED | Results posted: 2012-10-03